Access cutting-edge chronic myeloid leukemia treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access chronic myeloid leukemia specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic myeloid leukemia treatment provided free
This study is a multicenter Phase 2, non-randomized, open-label single-group frontline study administering asciminib in patients with newly diagnosed Chronic Myeloid Leukemia-Chronic Phase (CML-CP). The aim of this study is to evaluate the efficacy and safety of asciminib in newly diagnosed CML-CP. Patients will receive asciminib 80 mg orally once daily during the single asciminib phase. Response is determined by PCR (polymerase chain reaction) blood test during the study. Patients who have not
Sponsor: Augusta University
Check if you qualify for this chronic myeloid leukemia clinical trial in Detroit, MI
If you're searching for chronic myeloid leukemia treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myeloid leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.